News & Articles
Selected Filters:
Abbott introduces NeuroSphere™ Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the U.S.
Newly FDA-approved system allows a patient to both communicate with a physician and remotely receive stimulation settings in real time regardless of location
‘Backup’ pacemaker discovery in goats could have important implications for human hearts
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
Natera and Personalis partner for personalized monitoring in oncology
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
The power of high-sensitivity troponin assays in the emergency department
Catch up on part one of our exclusive webinar series to hear Dr. Frank Peacock dispel the four lies of high-sensitivity troponin
6 top webinars coming up this week
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
The importance of pediatric reference intervals for diagnostic testing
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar
How to tackle the emerging COVID-19 variants
Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics
Hologic introduces 3D breast ultrasound imaging on SuperSonic MACH Systems in Europe
Advancement can enable greater certainty for providers and better outcomes for patients
Thermo Fisher Scientific to acquire point-of-care molecular diagnostics provider Mesa Biotech
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
The mysteries of intensive care medicine unraveled: Watch on demand
Learn about why patients are admitted to an ICU, the physiological support, monitoring, and treatments available and the impact COVID-19 globally
Technology Trends in Clinical Diagnostics and Research: The Very Best of 2018
Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months
Beckman Coulter launches one of the first high-quality, high-throughput COVID-19 antigen test ideal for mass testing in the U.S.
The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable
























